Product Information

BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $8.1880 per ML under NDC 00378705567. Its NADAC has been published 274 times since Aug 18, 2021.

FDA first approved this application on Mar 18, 2019. Its Orange Book therapeutic-equivalence code is AT.

BEPOTASTINE 1.5% EYE DROP

Bepotastine Besilate
$8.1880per ML

Strength

15 mg/mL

NDC

00378705567

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BEPOTASTINE BESILATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206220

FDA Approved

3/18/2019

TE Code

AT

On Market Since

5/28/2021

Pharmacological Classes

Price Statistics

The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 274 times since Aug 18, 2021, and over the history we have for it it has declined 77.3%. The table below summarizes its recorded NADAC range and movement.

Current price$8.1880 per ML
All-time high$36.0376 (Dec 15, 2021)
All-time low$8.1880 (Oct 21, 2026)
52-week high$14.6349
52-week low$8.1880
Median price$17.3831
Average price$19.7672
Largest weekly change-29.4% (May 18, 2022)
Weeks tracked274
Tracking sinceAug 18, 2021

Price History

1W

0.0%

1M

-1.2%

3M

-1.5%

6M

-27.9%

1Y

-43.7%

3Y

-61.8%

5Y

-77.3%

All

-77.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Mylan Pharmaceuticals Inc., is $8.1880 per ML (NDC 00378705567), effective Nov 11, 2026.

How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 77.3%. It has been tracked across 274 weekly CMS publications since Aug 18, 2021.

What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?

Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $8.1880 (Oct 21, 2026) to a high of $36.0376 (Dec 15, 2021), with a median of $17.3831 per ML.

Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BEPOTASTINE 1.5% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures BEPOTASTINE 1.5% EYE DROP?

BEPOTASTINE 1.5% EYE DROP (NDC 00378705567) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.